famotidine
Generic: famotidine
Labeler: zydus pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
famotidine
Generic Name
famotidine
Labeler
zydus pharmaceuticals usa inc.
Dosage Form
POWDER, FOR SUSPENSION
Routes
Active Ingredients
famotidine 40 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
68382-444
Product ID
68382-444_707e6805-7f07-43d1-b65b-4afbb9e9e95e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091020
Listing Expiration
2026-12-31
Marketing Start
2021-04-22
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68382444
Hyphenated Format
68382-444
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
famotidine (source: ndc)
Generic Name
famotidine (source: ndc)
Application Number
ANDA091020 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/5mL
Packaging
- 50 mL in 1 BOTTLE, PLASTIC (68382-444-05)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "707e6805-7f07-43d1-b65b-4afbb9e9e95e", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0368382444059"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["a8010e10-68fd-455f-968f-d62a1c3e0ffd"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE, PLASTIC (68382-444-05)", "package_ndc": "68382-444-05", "marketing_start_date": "20210422"}], "brand_name": "FAMOTIDINE", "product_id": "68382-444_707e6805-7f07-43d1-b65b-4afbb9e9e95e", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "68382-444", "generic_name": "famotidine", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA091020", "marketing_category": "ANDA", "marketing_start_date": "20210422", "listing_expiration_date": "20261231"}